Tags:CartCultureDataDevelopmentGrowthITMachine LearningMaterialsPlatformTechnology
Erbi Biosystems is revolutionizing cell therapy and bioprocessing process development with the Breez, a fully automated 2 mL TruePerfusion™ bioreactor.  Scarce and expensive raw materials no longer restrict generation of process development data enabling improved CMC.  A single 2mL volume cassette can deliver up to 400M (CHO and T-cells), sufficient for most development needs and a number of CAR-T clinical dose regimes. The platform offers a 90% footprint reduction using disposable, functionally closed single-use cassettes with proprietary microfluidic technology processes capable of performing activation, transduction, intensified growth, and diafiltration steps. It offers closed-loop control of pH, total cell density (OD), dissolved oxygen, and CO2 measurements. The integrated online sensors and intuitive software deliver sophisticated feeding strategies, increased cell concentration, low shear, bubble-free mixing with high kLa resulting in performance far exceeding the static and benchtop reactors typically used today. #CellTherapy4All  #CellTherapyforAll
Member count: 11-50
Total raised: $3.8M
Founded date: 2006

Investors 1

DateNameWebsite
29.01.2023Bantam Gro...bantamgrou...

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
02.11.2020-$3.8M-finsmes.co...

Mentions in press and media 4

DateTitleDescriptionCategoryAuthorSource
04.01.2022Erbi Biosy...CAMBRIDGE, Mass., Jan. 4, 2022...--marketscre...
02.11.2020Erbi Biosy...Erbi Biosystems, a Woburn, MA-...USA-finsmes.co...
30.10.2020Erbi Biosy...Erbi Biosystems, a transformat...--citybizlis...
-Erbi Biosy...Erbi Biosystems recently annou...--pulse2.com...